| Ytd | -0.17% | |
| 1y | 53.81% |
| Open | 5.89 | Prev Close | 5.85 | Low | 5.78 | High | 5.89 | Mkt Cap | 60.30M |
| Vol | 2.38K | Avg Vol | 494.79K | EPS | -2.82 | P/E | -2.07 | Forward P/E | -1.34 |
| Beta | 0.92 | Short Ratio | 1.90 | Inst. Own | 12.91% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 6.16 | 200-d Avg | 6.54 | 1yr Est | 45.17 |
CLNN News
Clene (CLNN) appears to have found support after losing some value lately, as indicated by the forma
Clene Inc. (CLNN) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estim
After successful completion of FDA Type C meeting, Clene expects to submit an NDA for CNM-Au8 ® unde
SALT LAKE CITY, May 05, 2026 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiar
SALT LAKE CITY, May 05, 2026 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiar
Clene Inc. (NASDAQ:CLNN) shares are up 6.68% on Monday as the company is filing for accelerated appr
FDA stated that the “proposed data may be capable of supporting the submission and review of an [NDA
Clene Inc. (NASDAQ: CLNN - Get Free Report) major shareholder Chidozie Ugwumba sold 7,748 shares of
Clene Inc. (NASDAQ: CLNN - Get Free Report) major shareholder Chidozie Ugwumba sold 6,374 shares of
Clene Inc. (NASDAQ: CLNN - Get Free Report) major shareholder Chidozie Ugwumba sold 25,040 shares of
In-person Type C FDA meeting scheduled by end of the first quarter of 2026 to discuss the latest CNM
SALT LAKE CITY, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidia
Ventyx Biosciences (NASDAQ: VTYX - Get Free Report) and Clene (NASDAQ: CLNN - Get Free Report) are b
Clene Inc. (NASDAQ: CLNN - Get Free Report) has been assigned an average rating of "Moderate Buy" fr
SALT LAKE CITY, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidia
Shares of Clene Inc. (NASDAQ: CLNN - Get Free Report) have earned an average recommendation of "Mode
Clene (NASDAQ: CLNN) executives told investors the clinical-stage biopharmaceutical company has secu
Clene Inc. (NASDAQ: CLNN - Get Free Report) major shareholder Chidozie Ugwumba sold 19,621 shares of
Clene Inc. (NASDAQ: CLNN - Get Free Report) major shareholder Chidozie Ugwumba sold 12,563 shares of
Clene Inc. (NASDAQ: CLNN - Get Free Report) major shareholder Chidozie Ugwumba sold 26,105 shares of
During the session on Thursday, 461 stocks hit new 52-week lows.
On Tuesday, 838 companies hit new 52-week lows.
During Monday's session, 402 companies made new 52-week lows.
On Wednesday, 807 companies reached new 52-week lows.